If a bladder cancer patient carries the same mutation and HLA allele with existing patients, such as TP53 R248W and HLA-A02:01, the corresponding neoantigen can be retrieved from the ‘Browse’ page directly. This evidence concerns the gene TP53 and urinary bladder carcinoma.